|
GO_0030260
|
GO_0030260 |
|
|
chromosome condensation
|
GO_0030261 |
|
|
apoptotic nuclear changes
|
GO_0030262 |
|
|
cellular component disassembly involved in execution phase of apoptosis
|
GO_0006921 |
|
|
apoptotic chromosome condensation
|
GO_0030263 |
|
|
nuclear fragmentation involved in apoptotic nuclear change
|
GO_0030264 |
|
|
nuclear membrane organization
|
GO_0071763 |
|
|
phospholipase C-activating rhodopsin mediated signaling pathway
|
GO_0030265 |
|
|
phospholipase C-activating G protein-coupled receptor signaling pathway
|
GO_0007200 |
|
|
rhodopsin mediated signaling pathway
|
GO_0016056 |
|
|
quinate 3-dehydrogenase (NAD+) activity
|
GO_0030266 |
|
|
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
GO_0016616 |
|
|
glyoxylate reductase (NADP+) activity
|
GO_0030267 |
|
|
glyoxylate reductase activity
|
GO_0106345 |
|
|
methylenetetrahydromethanopterin dehydrogenase activity
|
GO_0030268 |
|
|
oxidoreductase activity, acting on the CH-NH group of donors
|
GO_0016645 |
|
|
tetrahydromethanopterin S-methyltransferase activity
|
GO_0030269 |
|
|
S-methyltransferase activity
|
GO_0008172 |
|
|
5-methyl-5,6,7,8-tetrahydromethanopterin-dependent methyltransferase activity
|
GO_0042086 |
|
|
transmembrane receptor protein tyrosine kinase inhibitor activity
|
GO_0030293 |
|
